MYL9 and urinary bladder cancer: High levels of expression of TPM2 (p = 0.0033), MYH11 (p = 0.04), TAGLN (p = 0.0088), CNN1 (p = 0.014), ACTC1 (p = 0.0085), FLNC (p = 0.00067), LMOD1 (p = 0.01), and CSRP1 (p = 0.0036) were found to be significantly associated with OS in patients with bladder cancer, while MYL9 (p = 0.061) and VIM (p = 0.14), as shown in Figure 7C.